IONS Competitors & Alternatives

Compare Ionis Pharmaceuticals Inc with similar stocks in the same industry

Biotechnology

IONS

Main Stock
$28.57
-1.70%
Tradestie Score
56
Market Cap
$10.49B
Revenue Growth
54.9%
Analyst Upside
+142.0%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: antisense oligonucleotides, RNA-targeted therapeutics
Major Customers 5
Biogen AstraZeneca Novartis rare disease patients specialty pharmacies
Critical Suppliers 2
contract oligonucleotide manufacturers raw material suppliers
Direct Ecosystem Rivals 4

Top Competitors

215 stocks in Biotechnology
Company Price Market Cap P/E Score Action
KRYS Krystal Biotech, Inc. Common Stock
$297.67
-2.48%
$5.20B 41.5 47 Compare
PCVX Vaxcyte, Inc. Common Stock
$62.02
-2.13%
$4.94B - 45 Compare
PTCT PTC Therapeutics, Inc.
$61.62
-2.95%
$4.93B - 43 Compare
ARWR Arrowhead Research Corporation
$44.57
-6.72%
$4.84B - 45 Compare
ACLX Arcellx, Inc. Common Stock
$115.07
+0.03%
$4.55B - 50 Compare
PTGX Protagonist Therapeutics, Inc
$125.40
-4.24%
$3.98B 28.1 42 Compare
CRNX Crinetics Pharmaceuticals, Inc.
$84.95
+0.13%
$3.92B - 46 Compare
KYMR Kymera Therapeutics, Inc. Common Stock
$124.79
-2.18%
$3.91B - 47 Compare
ZLAB Zai Lab Limited American Depositary Shares
$23.74
-3.50%
$3.83B - 44 Compare
AAPG Ascentage Pharma Group International American Depository Shares
$13.43
-8.14%
$3.68B - 51 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

215 stocks in this industry